Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
1 For healthcare organizations and businesses, this presents a unique opportunity to get ahead of the curve by implementing a direct-to-consumer GLP-1 prescription program
GLP-1RAs such as liraglutide, semaglutide, dulaglutide, and others compared to placebo were assessed
The appetite-suppressing effects of GLP-1 medications support these efforts by reducing hunger and cravings, making it easier to adhere to calorie-controlled diets and exercise routines
Shapely can help patients access self-pay programs for FDA-approved medications, such as Wegovy through NovoCare and Zepbound through Lilly Direct, which may offer discounted pricing for eligible patients
